4.8 Article

Thromboinflammation Supports Complement Activation in Cancer Patients With COVID-19

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Immunology

Complement Activation in the Disease Course of Coronavirus Disease 2019 and Its Effects on Clinical Outcomes

Aline H. de Nooijer et al.

Summary: In COVID-19 patients, activation of the complement system is associated with disease severity, mortality rate, and thromboembolic events. This suggests components of the complement system could serve as potential prognostic markers and therapeutic targets in COVID-19.

JOURNAL OF INFECTIOUS DISEASES (2021)

Review Urology & Nephrology

Immunity, endothelial injury and complement-induced coagulopathy in COVID-19

Luca Perico et al.

Summary: This review provides insights into the pathogenic mechanisms and clinical manifestations of COVID-19, highlighting the critical role of the immunological hyper-response induced by SARS-CoV-2 infection. The authors emphasize the importance of early diagnosis and intervention in controlling disease progression.

NATURE REVIEWS NEPHROLOGY (2021)

Article Virology

Tocilizumab administration is associated with the reduction in biomarkers of coronavirus disease 2019 infection

Timotius Ivan Hariyanto et al.

Summary: Meta-analysis study suggests that tocilizumab treatment is effective in reducing the biomarkers of COVID-19 infection.

JOURNAL OF MEDICAL VIROLOGY (2021)

Review Emergency Medicine

Inflammatory and hematologic markers as predictors of severe outcomes in COVID-19 infection: A systematic review and meta-analysis

Timotius Ivan Hariyanto et al.

Summary: The meta-analysis suggests that COVID-19 patients with elevated procalcitonin, CRP, D-dimer, and LDH levels, as well as decreased albumin levels, may be more likely to develop severe outcomes.

AMERICAN JOURNAL OF EMERGENCY MEDICINE (2021)

Article Immunology

Complement Overactivation and Consumption Predicts In-Hospital Mortality in SARS-CoV-2 Infection

Gyorgy Sinkovits et al.

Summary: Uncontrolled complement activation is associated with advanced disease severity of COVID-19, with patients more likely to die when accompanied by overactivation and consumption of C3. These findings support the potential use of complement inhibitory drugs in the treatment of COVID-19.

FRONTIERS IN IMMUNOLOGY (2021)

Article Immunology

Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection

Lina Ma et al.

Summary: Complement activation is elevated in patients with COVID-19 and is associated with severe illness, endothelial injury, and hypercoagulability, serving as a distinctive feature of COVID-19 and providing specific targets for risk prognostication and drug discovery.

SCIENCE IMMUNOLOGY (2021)

Review Chemistry, Medicinal

Efficacy and Safety of Tocilizumab for Coronavirus Disease 2019 (Covid-19) Patients: A Systematic Review and Meta-analysis

Timotius Ivan Hariyanto et al.

Summary: The study found that tocilizumab can reduce the mortality rate of COVID-19 patients, but does not affect the severity of the disease and length of hospital stay. Additionally, it is not associated with more serious adverse events compared to standard care treatment. Future research should focus on other potential therapies for COVID-19 patients.

DRUG RESEARCH (2021)

Article Medicine, General & Internal

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Chaolin Huang et al.

LANCET (2020)

Review Immunology

COVID-19 as an Acute Inflammatory Disease

Rose H. Manjili et al.

JOURNAL OF IMMUNOLOGY (2020)

Letter Medicine, General & Internal

Endothelial cell infection and endotheliitis in COVID-19

Zsuzsanna Varga et al.

LANCET (2020)

Review Medicine, Research & Experimental

Rationale for targeting complement in COVID-19

Anastasia Polycarpou et al.

EMBO MOLECULAR MEDICINE (2020)

Editorial Material Hematology

Coagulation abnormalities and thrombosis in patients with COVID-19

Marcel Levi et al.

LANCET HAEMATOLOGY (2020)

Article Biochemistry & Molecular Biology

Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection

Vijendra Ramlall et al.

NATURE MEDICINE (2020)

Article Multidisciplinary Sciences

Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients

Jan C. Holter et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Article Immunology

Pathology and Pathogenesis of SARS-CoV-2 Associated with Fatal Coronavirus Disease, United States

Roosecelis B. Martines et al.

EMERGING INFECTIOUS DISEASES (2020)

Review Biochemistry & Molecular Biology

Serum amyloid A - a review

George H. Sack

MOLECULAR MEDICINE (2018)

Review Immunology

Pentraxins in Complement Activation and Regulation

Ying Jie Ma et al.

FRONTIERS IN IMMUNOLOGY (2018)

Review Immunology

Complement in Immune and Inflammatory Disorders: Pathophysiological Mechanisms

Daniel Ricklin et al.

JOURNAL OF IMMUNOLOGY (2013)

Review Cell Biology

Complement and its role in innate and adaptive immune responses

Jason R. Dunkelberger et al.

CELL RESEARCH (2010)

Article Immunology

Molecular Intercommunication between the Complement and Coagulation Systems

Umme Amara et al.

JOURNAL OF IMMUNOLOGY (2010)